Results 141 to 150 of about 70,014 (324)

Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction‐Associated Steatotic Liver Disease

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The impacts of cardiometabolic risk factors (CMRFs) and the biomarkers on disease severity in metabolic dysfunction‐associated steatotic liver disease (MASLD) remain elusive. Accordingly, a multicenter study by recruiting MASLD patients from a nationwide registry database was conducted with a total of 2882 MASLD patients (54.1% males, mean age 
Jee‐Fu Huang, Chi‐Yi Chen, Ming‐Jong Bair, Tzu‐Chun Lin, Ming‐Lun Yeh, Pei‐Chien Tsai, Yu‐Ju Wei, Chih‐Wen Wang, Po‐Chen Liang, Ming‐Yen Hsieh, Mei‐Hsuan Lee, Chia‐Yen Dai, Chung‐Feng Huang, Ming‐Lung Yu, Wan‐Long Chuang   +14 more
wiley   +1 more source

Palmitic Acid Alters Longitudinal Bone Growth While Enhancing Matrix Maturation in an Organotypic Bone Model. [PDF]

Biomolecules
Poskevicius L, Martin V, Cardoso JG, Juodžbalys G, Gomes PS.   +4 more
europepmc   +1 more source

Hyperlipidemias

, 2001

core   +1 more source

CLINICAL UTILIZATION OF LIPID PROFILES AND GENETICS OF LIPID METABOLISM

Lipid testing provides vital information for cardiovascular risk stratification and prevention decision-making. This article overviews evidence-based approaches to screening, risk evaluation, diagnosis of familial hyperlipidemias, and employing emerging ...
Kumar, Pawan
core   +1 more source

Olfactory Dysfunction and Metabolic Syndrome Components: A Systematic Review and Meta‐Analysis

The Laryngoscope, EarlyView.
ABSTRACT Objective To elucidate the association between olfactory dysfunction (OD) and metabolic syndrome components. Data Sources PubMed (National Library of Medicine—National Institutes of Health), Scopus (Elsevier), CINAHL Complete (EBSCOhost), and the Cochrane Library (Wiley) databases were searched from inception through March 23rd, 2026.
Neeti Gandra, Kaitlyn A. Roberts, Shaun A. Nguyen, Pete Peters, Lauren A. Howser, Zachary M. Soler, Rodney J. Schlosser   +6 more
wiley   +1 more source

Clinical efficacy of combining fenofibrate with statins in patients with diabetes and hyperlipidemia: a meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Huang J, Meng K, Qiu H.
europepmc   +1 more source

Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias.

American Journal of Clinical Nutrition, 1991
A. Qureshi, N. Qureshi, Judith Hasler-Rapacz, F. E. Weber, V. Chaudhary, T. Crenshaw, A. Gapor, A. Ong, Y. Chong, D. M. Peterson   +9 more
semanticscholar   +1 more source

Slow‐Phase Nystagmus Velocity as a Risk Factor for Lateral Canal BPPV Recurrence

The Laryngoscope, EarlyView.
This study investigated slow‐phase nystagmus velocity (SPV) at initial diagnosis as an objective vestibular predictor for the recurrence of lateral semicircular canal benign paroxysmal positional vertigo (BPPV). Binomial logistic regression analysis demonstrated that an elevated initial SPV is a novel, independent risk factor for recurrence ...
Chung Yoh Kim, Woo Jin Kim
wiley   +1 more source

Pilot study of the use of ezetimibe in dogs with hyperlipidemia. [PDF]

Vet Res Commun
de Lima Wachholz P, Bierhals ES, de Lima CM, Grala CX, de Freitas VR, Jorge S, Bruhn FRP, de Oliveira Nobre M, Rondelli MCH.   +8 more
europepmc   +1 more source

The Role and Assessment of Lipid Profile in Patients With a Chronic Total Coronary Occlusion

Lipids, EarlyView.
This review summarized evidence on lipid profiles in CTO patients, non‐CTO patients, and healthy individuals, and examined the reported associations between lipid parameters, collateral channel formation, and clinical outcomes. Several key findings emerged from the present study.
Karol Sadowski, Dominika Tomkiel, Roel Hoek, Ruben W. de Winter, Nick S. Nurmohamed, Bimmer E. P. M. Claessen, Niels J. Verouden, Alexander Nap, Sebastiaan A. Kleijn, Mariusz Tomaniak, Yvemarie B. O. Somsen, Paul Knaapen   +11 more
wiley   +1 more source